Adaptive Biotechnologies Corp. (ADPT)
13.87
-0.09
(-0.64%)
USD |
NASDAQ |
May 21, 16:00
13.87
0.00 (0.00%)
After-Hours: 19:45
Adaptive Biotechnologies Cash from Investing (Quarterly) : 9.143M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | -8.961B |
| Sotera Health Co. | -45.13M |
| FONAR Corp. | -0.173M |
| ICON plc | -59.31M |
| Interpace Biosciences, Inc. | -0.141M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.537M |
| Cash from Financing (Quarterly) | 7.50M |
| Free Cash Flow | -29.54M |
| Free Cash Flow Per Share (Quarterly) | -0.0664 |
| Free Cash Flow to Equity (Quarterly) | -8.158M |
| Free Cash Flow to Firm (Quarterly) | -7.444M |
| Free Cash Flow Yield | -1.37% |